Hypersensitivity to montelukast or cetirizine hydrochloride, to any of the excipients, to hydroxyzine or to any piperazine derivatives. Patients with severe renal impairment at less than 10 ml/min creatinine clearance.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
